CLOSE X

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE997.0044.2 (+4.64 %)
PREV CLOSE ( ) 952.80
OPEN PRICE ( ) 953.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 117062
TODAY'S LOW / HIGH ( )953.75 1003.70
52 WK LOW / HIGH ( )660.05 1059.6
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing : BSE, NSE
NEWS
04Mar Natco Pharma launches Pomalidomide cap
Natco Pharma, along with its partner Breckenridge Pharmaceutical, has la..
04Mar Natco Pharma rises on launching Pomali
Natco Pharma is currently trading at Rs. 965.00, up by 8.60 points or 0...
25Feb Natco Pharma informs about clarificati
Natco Pharma has clarified that they made all necessary disclosures purs..
25Feb Clarification sought from Natco Pharm
The Exchange has sought clarification from Natco Pharma Ltd on February..
24Feb Clarification sought from Natco Pharm
The Exchange has sought clarification from Natco Pharma Ltd on February..
Financials
Rs. in Millions
QTR Dec 25 ANNUAL 25
Net Profit106918504
Gross Profit 1252 22260
Operating Profit 175624656
Net Sales 528840945
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Acutaas Chemicals (BSE)
 2246.00 (6.74%)
M.Cap ( in Cr)18388.25
Neuland Laboratories (BSE)
 12866.65 (0.71%)
M.Cap ( in Cr)16507.77
Onesource Specialty (BSE)
 1425.00 (6.67%)
M.Cap ( in Cr)16333.52
Sanofi Cons. Health (BSE)
 4304.00 (1.90%)
M.Cap ( in Cr)9912.38
Glenmark Pharma (BSE)
 2105.90 (3.23%)
M.Cap ( in Cr)59428.67
Shareholding Pattern
PROMOTERS 49.48%
NON-INSTITUTION 29.97%
FI/BANKS/INSURANCE 3.5%
MUTUAL FUNDS/UTI 1.6%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data February 2026 Broking Complaints Data February 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.